The Invisible Border: How Funding Bans and Drug Shortages are Fueling a Syphilis Crisis in San Diego’s Shadows
She first came to Park Boulevard for the money and the snacks, a pilgrimage born...
She first came to Park Boulevard for the money and the snacks, a pilgrimage born...
In a pivotal legal decision that carries profound implications for the American social safety net,...
In a pivotal session that underscores the shifting landscape of American public health governance, the...
The biotechnology sector is currently navigating a period of intense regulatory scrutiny, executive turnover, and...
This legal action is not an isolated incident but rather part of a broader regulatory...
The Food and Drug Administration (FDA) has convened its Cellular, Tissue, and Gene Therapies Advisory...
The landscape of pain management, long dominated by the shadow of the opioid crisis and...
The landscape of American scientific research is currently weathering a period of profound structural transformation,...
The decision centers on the termination of what policy experts call the "Premium Stabilization Demonstration,"...
The most visible symbol of this friction remains Dr. Anthony Fauci, the former director of...